NTRS:NASDAQNorthern Trust Corporation Analysis
Data as of 2026-03-10 - not real-time
$139.44
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Northern Trust is trading near its short‑term support while the 20‑day moving average sits just below the 50‑day average, indicating a modest upward bias but the 200‑day average remains well above current levels, suggesting the longer trend is still neutral. The RSI is in the low‑forties, the MACD histogram is negative and the signal line is bearish, reinforcing a cautious stance on immediate price momentum. Recent news of a new asset‑servicing mandate with CK Capital Partners and the expansion of dynamic currency‑hedging capabilities add a positive catalyst to the fundamentals. Fundamentally, the company’s price‑to‑earnings ratio trails the industry average, the dividend yield sits comfortably above two percent with a payout ratio under forty percent, and the discounted cash‑flow model points to a modest upside of roughly twelve percent. Strong operating margins and a solid balance sheet, highlighted by ample cash relative to debt, support the view that earnings quality is sound. Overall, the stock appears undervalued with stable cash generation and a dividend that can be sustained, but technical indicators advise patience.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and neutral RSI suggest limited upside in the near term
- Price is near established support, limiting downside risk
- Attractive dividend yield provides income while waiting for catalyst
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Valuation gap to industry peers and DCF upside
- Revenue growth and expanding fee‑based services
- Sustainable dividend supports total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash position and disciplined balance‑sheet management
- Diversified asset‑servicing and wealth‑management franchise
- Long‑term secular demand for custodial and advisory services
Key Metrics & Analysis
Financial Health
Revenue Growth8.20%
Profit Margin21.46%
P/E Ratio16.0
ROE13.49%
ROA1.04%
P/B Ratio2.2
Op. Cash Flow$5.5B
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI42.2
Support$132.77
Resistance$155.31
MA 20$144.06
MA 50$145.43
MA 200$131.28
MACDBearish
VolumeStable
Fear & Greed Index80.68
Valuation
Fair Value$369.96
Target Price$157.11
Upside/Downside12.67%
GradeUndervalued
TypeBlend
Dividend Yield2.28%
Risk Assessment
Beta1.16
Volatility29.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.